A Phase II Study of TAK-228 in patients with previously

Project: Research project

Project Details

Description

A Phase II Study of TAK-228 in patients with previously treated metastatic renal cell carcinoma
StatusFinished
Effective start/end date9/1/179/30/22

Funding

  • DANA-FARBER CANCER INSTITUTE
  • MILLENNIUM PHARMACEUTICALS, INC.

Fingerprint

Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.